EQ Competitors & Alternatives

Compare Equillium Inc with similar stocks in the same industry

Biotechnology

EQ

Main Stock
$1.06
-5.36%
Tradestie Score
47
Market Cap
$88.06M
Revenue Growth
-52.3%
Analyst Upside
+707.1%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: monoclonal antibody modulation, CD6 pathway inhibition
Major Customers 3
Biocon Limited clinical research organizations academic medical centers
Critical Suppliers 2
contract manufacturing organizations CROs for clinical trials
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.39
-2.27%
$154.27M - 38 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$6.58
-6.00%
$137.59M - 36 Compare
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
INMB INmune Bio Inc. Common stock
$0.83
-7.50%
$56.63M - 42 Compare
ECOR electroCore, Inc. Common Stock
$4.42
-8.87%
$37.46M - 41 Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry